
LG Chem Expands into the Chinese Market for Osteoarthritis Treatment
LG Chem is actively pursuing entry into the Chinese osteoarthritis treatment market. Recently, LG Chem disclosed that its partner in China, Yifan Pharmaceutical, has launched Synovian (known as Hyruan One in China), LG Chem’s single-injection osteoarthritis treatment, into the Chinese…












